Amazon.com has been one of the most innovative and disorganized companies of this century, with incredible success in areas beyond historically considered its core business (book sales). Thus every ad or speculation Amazon AMZN, -0.96% Whoever enters a particular industry sends the shares of that industry into the tailspin. Investors …
Read More »FDA pulls J & J’s Invokana alert in boxes after reviewing amputation risks – but sales damage done
Sales of Johnson & Johnson’s diabetes drug Invokana have suffered since the FDA put a warning in the box on the label describing the product’s amputation risks. But in a nutshell, the bureau now says this warning has been removed. The FDA this week scrapped the warning in the box …
Read More »Pfizer could quickly score COVID-19 vaccine nod, thanks to Hahn’s October FDA review promise: analyst
FDA Commissioner Stephen Hahn, MD, was fresh from a controversy over the authorization for emergency use of restorative plasma to treat COVID-19 when he made waves again, this time promising on Twitter that the agency would review coronavirus vaccines for the elections of November. And Pfizer executives seem to be …
Read More »Outlook on Moderna too rosy among multiple potential COVID-19 faxes: analyst
Moderna’s mRNA COVID-19 vaccine candidate was the first U.S. shot to enter late-stage testing, but that does not necessarily mean it has the brightest future of all. The high possibility of multiple emergency authorizations for coronavirus vaccines towards the end of the year speaks to a lot of competition – …
Read More »A common medication for older adults improves COVID-19 survival rates, say researchers
Medications for high blood pressure could improve survival rates for people suffering from COVID-19 and reduce the severity of infection, according to new research from a team of scientists at the University of East Anglia in the UK and published Monday in the Journal Current Atherosclerosis Reports, a bilingual peer-reviewed …
Read More »